Application of Microfluidic Systems for Breast Cancer Research

Area of Science:

• Oncology
• Biomedical Engineering
• Microfluidics

Background:

• Breast cancer is a prevalent disease, with metastasis being the primary cause of mortality.
• Traditional cell cultures and animal models have limitations in replicating the in vivo microenvironment for breast cancer research.
• Microfluidics and organ-on-a-chip technology have emerged as innovative tools for biological research.

Purpose of the Study:

• To review the applications of microfluidics in breast cancer research, focusing on detection, dormancy, and therapeutic development.
• To highlight the advantages of microfluidic systems in mimicking in vivo microenvironments for more accurate breast cancer modeling.
• To discuss the potential of microfluidics to overcome limitations of conventional research models.

Main Methods:

• Development of microfluidic devices and organ-on-a-chip systems.
• Construction of 3D cellular co-cultures that mimic in vivo tissue microenvironments.
• Application of these systems to study breast cancer initiation, progression, metastasis, detection, dormancy, and therapeutic responses.

Main Results:

• Microfluidic systems provide a more physiologically relevant platform for studying breast cancer.
• These systems enable the investigation of complex processes like metastasis, dormancy, and recurrence.
• Microfluidics facilitates the development and testing of novel therapeutic strategies for breast cancer.

Conclusions:

• Microfluidics represents a paradigm shift in breast cancer research, offering enhanced predictive power over traditional models.
• The technology is crucial for advancing the understanding and treatment of breast cancer, including late recurrence.
• Future research will likely see increased integration of microfluidics to eradicate breast cancer.